Correction: Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia. - Vetro C; Garibaldi B; Grimaldi F; Chiusolo P; Filì C; Riva C; Cardinali V; Franciosa M; Pilo F; Palmieri R; Esposito L; Menotti D; et al. (Blood cancer journal, 2025)